1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,320 | 2,440 | 12:40 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | 1 | HKEx | ||
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 23.03. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 21.03. | Shanghai Haohai Biological Technology Co., Ltd Reports Retreat In Full Year Income | 2 | RTTNews | ||
| 20.03. | HAOHAI BIOTEC (06826): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | 3 | HKEx | ||
| 20.03. | HAOHAI BIOTEC (06826): DISCLOSURE PURSUANT TO RULE 14A.63 OF THE LISTING RULES | 1 | HKEx | ||
| 20.03. | HAOHAI BIOTEC (06826): ARTICLES OF ASSOCIATION | 2 | HKEx | ||
| 20.03. | HAOHAI BIOTEC (06826): AMENDMENTS TO THE ARTICLES OF ASSOCIATION | 1 | HKEx | ||
| 10.03. | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | 1 | HKEx | ||
| 06.03. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 27.02. | HAOHAI BIOTEC (06826): ANNOUNCEMENT OF PRELIMINARY ANNUAL RESULTS FOR THE YEAR 2025 | 2 | HKEx | ||
| 07.01. | HAOHAI BIOTEC (06826): SUPPLEMENTAL ANNOUNCEMENT - CONNECTED TRANSACTION - ACQUISITION OF EQUITY INTEREST IN JIANGXI RUIJI BIO-ENGINEERING TECHNOLOGY ... | 3 | HKEx | ||
| 29.12.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 23.12.25 | HAOHAI BIOTEC (06826): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.* ANNOUNCEMENT ON THE RECEIPT OF AN ADMINISTRATIVE ... | - | HKEx | ||
| 18.12.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 12.12.25 | HAOHAI BIOTEC (06826): CONNECTED TRANSACTION - ACQUISITION OF EQUITY INTEREST IN JIANGXI RUIJI BIO-ENGINEERING TECHNOLOGY CO., LTD.* | 1 | HKEx | ||
| 12.12.25 | HAOHAI BIOTEC (06826): CHANGE OF JOINT COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT | 1 | HKEx | ||
| 11.12.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 04.12.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 27.11.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 19.11.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 2,687 | +1,93 % | Valneva ÜBERRASCHT Anleger: Könnte die Aktie jetzt komplett durchstarten? - Das sollten Sie jetzt wissen | ||
| AMGEN | 296,40 | -0,40 % | BeOne wins China approval for Amgen's lung cancer drug Imdelltra | ||
| STRYKER | 293,40 | 0,00 % | Stryker To Buy Amplitude Vascular Systems | WASHINGTON (dpa-AFX) - Stryker Corporation (SYK), a medical technology company, said on Monday that it has signed a deal to buy Amplitude Vascular Systems, Inc., a privately held developer of... ► Artikel lesen | |
| REGENERON PHARMACEUTICALS | 646,60 | +0,95 % | Regeneron und Sanofi bekommen Dupixent-Zulassung für Kinder mit CSU | DJ Regeneron und Sanofi bekommen Dupixent-Zulassung für Kinder mit CSU
Von Colin Kellaher
DOW JONES--Regeneron Pharmaceuticals und Sanofi haben für ihren Blockbuster-Entzündungshemmer Dupixent... ► Artikel lesen | |
| CSL | 84,52 | +0,79 % | What on earth's going on with CSL shares? | ||
| BEONE MEDICINES LTD ADR | 264,00 | +0,76 % | BeiGene Q1 2026 Earnings Preview | ||
| CANSINO BIOLOGICS | 3,580 | -2,19 % | CanSino Biologics Inc: CanSinoBIO: From Profit Turnaround to Value Realization as an Innovative Vaccine Leader | HONG KONG, Mar 31, 2026 - (ACN Newswire) - HONG KONG, Mar 31, 2026 - (ACN Newswire) - China's 2026 Report on the Work of the Government identified biopharmaceuticals as an emerging pillar industry,... ► Artikel lesen | |
| BIOMERIEUX | 92,20 | +0,11 % | BioMerieux SA Profit Declines In Full Year | PARIS (dpa-AFX) - BioMerieux SA (EYWN.MU) reported earnings for full year that Drops, from the same period last yearThe company's bottom line totaled EUR397.5 million, or EUR3.34 per share.... ► Artikel lesen | |
| SINO BIOPHARM | 0,660 | +3,97 % | SINO BIOPHARMACEUTICAL 's Vetricotobat Monoclonal Antibody for Gastric Cancer Completes First Patient Enrollment in Phase III Clinical Trial | ||
| ZAI LAB LTD ADR | 18,600 | 0,00 % | ZAI LAB (09688): GRANT OF SHARE OPTIONS, RESTRICTED SHARE UNITS AND PERFORMANCE SHARE UNITS | ||
| CSTONE PHARMACEUTICALS | 1,070 | +2,10 % | CStone Pharmaceuticals Places Shares at Nearly 7% Discount, Net Proceeds HKD1.053B | ||
| CASI PHARMACEUTICALS | 0,214 | -4,13 % | CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel | SOUTH SAN FRANCISCO, CA / ACCESS Newswire / February 25, 2026 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class... ► Artikel lesen | |
| 3SBIO | 2,766 | +10,20 % | M Stanley Trims 3SBIO TP to $34, Rating Overweight | ||
| GENSCRIPT BIOTECH | 1,430 | +2,88 % | GenScript Biotech Corporation: GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report | Advancing Climate Action, Governance Excellence, and Global Scientific ImpactPISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental... ► Artikel lesen | |
| IMMUNOVANT | 26,550 | 0,00 % | Immunovant Inc.: Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) | Phase 3 studies of batoclimab in thyroid eye disease (TED) each failed to meet their primary endpoint; safety results were consistent with previous findingsPatients in the TED studies demonstrated... ► Artikel lesen |
Das Unternehmen SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 2,320 Euro und damit -0,85 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD finden Sie auf Wallstreet Online.